After years of waiting, Canadian legislation designed to encourage shipments of low-cost HIV/AIDS drugs to developing countries has finally been put to use. Unfortunately, the
In 1999, between 1.3 and 2.1 billion people did not have access to essential medicines (around 30% of the world’s population), with most of these
Issues surrounding medicine patents truly test the moral groundings of patent law. Specifically, when companies develop and patent drugs that treat life threatening diseases, the
Thailand is at war, with battles taking place on several fronts. Over 600,000 people in Thailand are infected with HIV and the government is fighting
In 2003, the Tufts Center for the Study of Drug Development (“Tufts”) estimated the cost to develop a new drug to be in excess of
India’s rejection of Novartis’ claim on drug improvements highlights the flexibility of India’s patent laws. Such flexibility stands in sharp contrast to the World Trade
